Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 3
Submit an article Journal homepage
943
Views
0
CrossRef citations to date
0
Altmetric
Reply Letter

Response to article by Matthew Wasserman et al. (2018): “Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico”

Jorge A. GómezHealth Outcomes Department, GSK, Victoria, Buenos Aires, ArgentinaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-5459-4973View further author information
ORCID Icon,
Adriana Guzman HolstHealth Outcomes Department, GSK, Panama City, PanamaView further author information
&
Javier NietoMedical Affairs Department, GSK, Panama City, PanamaView further author information
Pages 570-571 | Received 06 Nov 2018, Accepted 23 Nov 2018, Published online: 20 Dec 2018

Figures & data

This paper does not have figures.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.